Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study

Fig. 2

a Kaplan–Meier curves of OS. For the analysis of OS, data for any patients who were dead at the time of the analysis were censored at the last recorded date on which the patient was known to be alive. Median OS: 34.0 months (95% CI, 28.8–unavailable). b Kaplan–Meier curves of PFS. Median PFS: 19.4 months (95% CI, 8.57–26.8). CI, confidence interval; HR, hazard ratio; OS, overall survival; PFS, progression-free survival

Back to article page